Full response of a localized renal tumour after reduced-intensity conditioned hematopoietic stem cell transplantation.

Case Reports in Medicine
Anne-Claire GacOumedaly Reman

Abstract

Graft versus tumor effect has been described in solid metastatic tumor. We reported here the case of a patient treated for an acute myeloid leukemia with reduced-intensity conditioned allograft and the effect of this procedure on concomitant of renal localised cancer. The effect of immune-mediated cytotoxicity on renal cancer is the more consistent explanation to understand the necrosis of this tumor. Any case of RIC allograft has been reported before to treat localised renal tumor.

References

Dec 9, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Scott S TykodiBrenda M Sandmaier
May 2, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L BarkholtUNKNOWN French ITAC group and the EBMT Solid Tumour Working Party
Jun 21, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Brian I RiniUNKNOWN Southwestern Oncology Group
Jan 16, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Naoto T Ueno, Richard W Childs

❮ Previous
Next ❯

Citations

Mar 24, 2010·Pediatric Clinics of North America·David BarrettStephan A Grupp

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.